Home Compare COHR vs GMED
Stock Comparison · Structural lead, mixed market

Coherent vs Globus Medical: Which Stock Looks Stronger in 2026?

Globus Medical holds the cleaner structural position, with the lead spread across profitability and valuation. Coherent still has the edge on growth, which keeps the comparison from looking entirely one-sided. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the Russell 1000 universe, making them directly comparable.

Updated 2026-08-16

This is not just a one-metric split: both profitability and valuation materially support the lead. Globus Medical, Inc. leads by 31 points on the overall comparison score.

Trajectory Similarity
0.60
Moderately similar
Peer-set rank: #10
within Coherent Corp.'s functional peer set

These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.

This level of similarity points to a meaningful structural match, though not a tight one.

The strongest overlap appears in margin trend and recent revenue growth.

Similarity drivers
margin trendrecent revenue growth
What reduces the match
revenue growth trajectory
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
COHR
Coherent Corp.
26
Peer-Score
Signal qualityMedium
Peer basis: Russell 1000
vs
GMED
Globus Medical, Inc.
57
Peer-Score
Signal qualityHigh
Peer basis: Russell 1000

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: COHR vs GMED Profitability 10 73 Stability 34 37 Valuation 23 82 Growth 45 15 COHR GMED
Gap Ranking
#1 Profitability +63
#2 Valuation +59
#3 Growth +30
#4 Stability +3
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for COHR and GMED Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer COHRGMED Relative valuation Structural strength

Globus Medical, Inc. looks stronger on relative valuation, while the broader price setup remains mixed.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Entry today — historical context

Where COHR and GMED each sit in their own 5-year price and valuation history.

BASED ON 5-YEAR HISTORY COHR Elevated · above norm 0th 50th 100th 6 pct gap GMED Elevated · below norm 0th 50th 100th 95th 89th
COHR (95th percentile) and GMED (89th percentile) both sit in the upper portion of their own 5-year ranges. The historical entry context is broadly similar for both. This reflects entry timing, not which company is structurally stronger.

Describes historical entry positioning only. Descriptive — not investment advice.

Relative Position vs Comparable Companies
Profitability
On profitability, Globus Medical, Inc. ranks near the top of the group; Coherent Corp. sits in the weaker half.
Valuation
On valuation, the gap still runs the same way: Globus Medical, Inc. sits near the top of the group, while Coherent Corp. remains in the weaker half.
Profitability — Dominant Gap
COHR
10
GMED
73
Gap+63in favour of GMED

The profitability lead is mainly driven by a 11.2-point operating margin advantage.

What keeps the gap from being one-sided

A meaningful counterforce remains in growth, which keeps the comparison from looking completely one-sided.

What this means for the comparison

The lead is built on both profitability and valuation — though growth still provides a counterweight.

Explore full peer positioning in AssetNext

Break down the COHR vs GMED comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how COHR and GMED each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.